John Millard is head of Technology Transfer at PSI. Intellectual property also falls within this area. In an interview, he tells how PSI protects its knowledge with patents and, thanks to its patents, further strengthens collaboration with industry and other research institutions.
At PSI, researchers develop innovative technologies, new biological agents, and more precise measuring instruments. Through this work they not only advance science, but also boost the Swiss economy. The best ideas are protected by patents and make PSI a sought-after partner for industry.
On 10 February, the ESA mission Solar Orbiter is scheduled to start. The Swiss X-ray telescope STIX will be launching too – with detectors developed at PSI.
PSI researchers have observed mechanical processes in solid-state batteries with unprecedented precision. Using X-ray tomography at the Swiss Light Source SLS, they discovered how fissures inside the batteries propagate. These insights can help to make batteries for electric cars or smartphones safer and more efficient.
PSI researchers are helping the European space program: Their neutron imaging serves to ensure the quality of critical components for rocket launches.
Electronics should get smaller, faster, and above all more energy-efficient. These themes are also present in several research groups at PSI. From incremental improvements to complete rethinking – who is currently working on what?
Fabia Gozzo is no woman for the comfort zone. First she made a beamline at the Swiss Light Source SLS of the Paul Scherrer Institute PSI into one of the world's leading facilities. Today she is making her knowledge available to industry with her spin-off.
A radioactive agent, developed at the Paul Scherrer Institute PSI to fight an especially malignant form of thyroid cancer, has the potential to become a blockbuster drug. Due to its structure, it might also be able to dock onto cells of other tumours and destroy them with its radiation. The Lausanne-based biopharmaceutical company Debiopharm wants to further develop the PSI agent to the point where it is approved as a drug. Debiopharm and PSI have now created the contractual basis for this.
Towards new shores: At the Paul Scherrer Institute PSI, enterprising researchers are venturing into the unknown. They're leaving their safe haven to become successful entrepreneurs. The journey from PSI to one's own spin-off takes courage. To keep the voyage from getting too stormy, PSI supports its business founders as they navigate through rough waters, and maintains these connections over many years.
The 16th of May is the International Day of Light. The research carried out with light at PSI enables advances in biology and pharmacology and also promotes the development of new materials for data storage and new technologies for personalised medicine.
The ABB facility in Wettingen got practical recommendations on increasing production of ceramic components. Researchers at the Paul Scherrer Institute PSI examined the components by means of neutron imaging. With the help of these images, ABB employees were able to see where there is still potential for process optimisation. This feasibility study was funded by the Hightech Zentrum Aargau.
Efficiently producing energy from biowaste: A technology developed at PSI and tested in collaboration with the Zurich-based energy provider Energie 360° makes it possible. It extracts significantly more methane from biowaste than conventional methods. For this important contribution to a sustainable energy supply, PSI and Energie 360° have now been awarded the Watt d'Or 2018 in the Renewable Energy category by the Swiss Federal Office of Energy.
Oles Sendetskyi, winner of a Founder Fellowship at the Paul Scherrer Institute PSI, wants to use polarity reversal in nanomagnets to develop a sustainable power source for small devices.
Jean-Baptiste Mosset, winner of a Founder Fellowship at the Paul Scherrer Institute PSI, wants to commercialise a neutron detector to spot plutonium and uranium.
With a new method for modifying antibodies, Philipp Spycher, winner of a Founder Fellowship at the Paul Scherrer Institute PSI, wants to develop drugs that are more stable and, thus, have fewer side-effects.
With a technology developed at the Paul Scherrer Institute PSI, around 60 percent more biogas can be produced from bio-waste than with conventional methods. But can it stand the test in practice as well? A 1,000-hour test at the Werdhölzli biowaste digestion and wastewater treatment plant in Zurich was able to answer this question with a clear yes. It was carried out in cooperation with the Zurich-based energy provider Energie 360°. The analysis of the stress test is now available.
Because of their high nitrogen content, spent coffee grounds are a popular garden fertilizer. Recycled in this manner, they already contribute to an environmentally friendly waste management. But they have the potential to deliver much more: a new procedure developed at the PSI allows high quality methane to be formed from spent coffee grounds. PSI researchers involved in a pilot project carried out in cooperation with the Swiss food producer Nestlé were able to show that spent coffee grounds left over during the production of instant coffee can be efficiently re-used elsewhere.
Within Switzerland’s bio-waste a huge amount of precious energy is hidden. That’s because valuable methane, the main constituent of natural gas, can be obtained from it. With a technology developed at PSI, the yield of methane from bio-waste could be increased considerably in the future. A long-term test conducted in cooperation with Energie 360° at the Werdhölzli fermentation and wastewater treatment plant is expected to advance this technology further along its path to industrial use.
This fall, the time has come: The Energy System Integration Platform at the Paul Scherrer Institute PSI goes into operation. Today, in the framework of the double conference Networked Energy Research Switzerland, it was presented to the media and around 150 representatives from politics, industry, and science.
A picture-perfect example of how basic research makes concrete contributions to the economy is the company DECTRIS — a PSI spin-off founded in 2006 and already highly successful. The latest development from DECTRIS is a detector called EIGER, which is used for X-ray measurements at large research facilities. There EIGER contributes, among other things, to the search for new drugs.